medigraphic.com

2022, Number 1

<< Back Next >>

Revista Colombiana de Bioética 2022; 17 (1)

Ethics of gene editing in humans

Penchaszadeh VB

Language: Spanish
References: 21
Page:
PDF size: 149.68 Kb.


ABSTRACT

Purpose/Context. This article discusses ethical aspects of gene editing in humans.
Methodology/Approach. The main applications of genetic technology in the prevention, diagnosis and therapeutics of genetic diseases in recent decades, are described, culminating with genetic editing.
Results/Findings. The main ethical aspects of somatic and germline gene editing in humans are discussed, including issues of safety, specificity, precision and certainty. Germline genetic editing and human “enhancement” are criticized for violating individual autonomy, for generating heritable genetic changes in the progeny and for accepting the fallacy of genetic reductionism that people’s traits depend exclusively on genetic makeup, independent of the environment.
Discussion/Conclusions/Contributions. Somatic gene editing can be ethical if the ethical standards of biomedical research are followed. However, germline genetic editing is not relevant nor necessary for the treatment of genetic diseases and, furthermore, it presents serious ethical conflicts. Therefore, prior to its application, a social consensus is necessary, obtained by democratic, broad and profound discussions among all the social players involved, followed by governance mechanisms with robust regulation by the state, which prevent the violation of fundamental human rights.


REFERENCES

  1. Bellver Capella, Vicente. 2016. “La revolución de la edición genética medianteCRISPR/cas 9 y los desafíos éticos y regulatorios que comporta.” Cuadernos deBioética XXVII, no. 2: 223-239.

  2. Chneiweiss, Hervé, François Hirsch, Lluis Montoliu, Albrecht M. Müller, SolveigFenet, Marion Abecassis, et al. 2017. “Fostering responsible research with genomeediting technologies: a European perspective.” Transgenic Research 26:709-713. https://doi.org/10.1007/s11248-017-0028-z

  3. Comité de Bioética de España. 2019. “Declaración sobre edición genómica enhumanos.” http://www.bioeticayderecho.ub.edu/es/declaracion-del-comite-de-bioetica-de-espana-sobre-la-edicion-genomica-en-humanos

  4. Consejo de Europa. 1997. “Convenio de Oviedo.” https://es.wikipedia.org/wiki/Convenio_sobre_Derechos_Humanos_y_Biomedicina

  5. Doudna, Jennifer y Samuel Sternberg. 2017. A crack in creation: gene editing and theunthinkable power to control evolution. Boston: Houghton Mifflin Harcourt.

  6. Eisenberg, Leon. 2005. “Are genes destiny? Have adenine, cytosine, guanine andthymine replaced Lachesis, Clotho and Atropos as the weavers of our fate?”World Psychiatry 4, no. 1: 3-8.

  7. European Group on Ethics in Science and New Technologies. 2021. Ethics of GenomeEditing. https://doi.org/10.2777/659034

  8. Evans, James, Eric M. Meslin, Theresa M. Marteau y Timothy Caulfield. 2011.“Deflating the Genomic Bubble.” Science 331, no. 6019: 861-862. https://doi.org/10.1126/science.1198039

  9. Krimsky, Sheldon. 2019. “Ten ways in which He Jiankui violated ethics.” NatureBiotechnology 37: 19-20. https://doi.org/10.1038/nbt.4337

  10. Lander, Eric, Françoise Baylis, Feng Zhang, Emmanuelle Charpentier, Paul Berg,Catherine Bourgain, et al. 2019. “Adopt a moratorium on human heritablegenome editing.” Nature 567: 165-168. https://doi.org/10.1038/d41586-019-00726-5

  11. Mojica, F, C Díez-Vilaseñor, J García-Martínez y C Almendros. 2009. “Short motifsequences determine the targets of the prokaryotic CRISPR defense system.”Microbiology 155: 3. https://doi.org/10.1099/mic.0.023960-0

  12. National Academies of Sciences, Engineering, and Medicine. 2017. Human GenomeEditing: Science, Ethics, and Governance. Washington, D. C.: The National AcademiesPress. https://doi.org/10.17226/24623

  13. National Academies of Sciences, Engineering, and Medicine. 2020. InternationalCommission on the Clinical Use of Human Germline Genome Editing. https://www.nationalacademies.org/our-work/international-commission-on-the-clinical-use-of-human-germline-genome-editing

  14. Normile, Dennis. 2018. “Shock greets claim of CRISPR-edited babies.” Science 362,no. 6418: 978-979. https://doi.org/10.1126/science.362.6418.978

  15. Penchaszadeh, Victor. 2012. “Genética, reduccionismo y derecho a la salud.” En:Genética y Derechos Humanos. Encuentros y Desencuentros, compilado por VíctorPenchaszadeh, 177-204. Buenos Aires: Paidós.

  16. Penchaszadeh, Victor. 2016. “Bioética y Tecnociencia.” Escritos 24, no. 53: 447-466. http://dx.doi.org/10.18566/escr.v24n53.a09

  17. Santaló, Josep y María Casado. 2016. Documento sobre bioética y edición genómica enhumanos. Barcelona, España: Edicions de la Universitat de Barcelona. http://hdl.handle.net/2445/105022

  18. Spinella, Liliana. 2015. “Análisis de las patentes de invención sobre genes humanosen torno al caso Association for Molecular Pathology et al v. Myriad GeneticsInc. et al.” RBD Revista de Bioética y Derecho 35. https://dx.doi.org/10.1344/rbd2015.35.14281

  19. Unesco. 2015. Report of the IBC on Updating Its Reflection on the Human Genome andHuman Rights. Estados Unidos: Unesco. https://unesdoc.unesco.org/ark:/48223/pf0000233258

  20. Weintraub, Karen. 2019. “Scientists call for a moratorium on editing inheritedgenes.” Scientific American, marzo 13, 2019. https://www.scientificamerican.com/article/scientists-call-for-a-moratorium-on-editing-inherited-genes/

  21. World Health Organization. 2021. WHO Expert Advisory Committee on DevelopingGlobal Standards for Governance and Oversight of Human Genome Editing. Ginebra,Suiza: WHO. https://www.who.int/publications/i/item/9789240030060




2020     |     www.medigraphic.com